Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead…
Biotechnology
US, Berkeley [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Caribou Biosciences, Inc. has no acquisition track records yet.
M&A Deals · History
Caribou Biosciences, Inc. has no acquisition track records yet.